IBDEI0J9 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9424,1,3,0)
 ;;=3^86486
 ;;^UTILITY(U,$J,358.3,9425,0)
 ;;=86580^^66^659^5^^^^1
 ;;^UTILITY(U,$J,358.3,9425,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9425,1,2,0)
 ;;=2^TB
 ;;^UTILITY(U,$J,358.3,9425,1,3,0)
 ;;=3^86580
 ;;^UTILITY(U,$J,358.3,9426,0)
 ;;=95024^^66^659^3^^^^1
 ;;^UTILITY(U,$J,358.3,9426,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9426,1,2,0)
 ;;=2^INTRADERMALS (EACH)
 ;;^UTILITY(U,$J,358.3,9426,1,3,0)
 ;;=3^95024
 ;;^UTILITY(U,$J,358.3,9427,0)
 ;;=86510^^66^659^2^^^^1
 ;;^UTILITY(U,$J,358.3,9427,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9427,1,2,0)
 ;;=2^HISTOPLASMOSIS
 ;;^UTILITY(U,$J,358.3,9427,1,3,0)
 ;;=3^86510
 ;;^UTILITY(U,$J,358.3,9428,0)
 ;;=99395^^66^660^1^^^^1
 ;;^UTILITY(U,$J,358.3,9428,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9428,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 18-39
 ;;^UTILITY(U,$J,358.3,9428,1,3,0)
 ;;=3^99395
 ;;^UTILITY(U,$J,358.3,9429,0)
 ;;=99396^^66^660^2^^^^1
 ;;^UTILITY(U,$J,358.3,9429,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9429,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 40-64
 ;;^UTILITY(U,$J,358.3,9429,1,3,0)
 ;;=3^99396
 ;;^UTILITY(U,$J,358.3,9430,0)
 ;;=99397^^66^660^3^^^^1
 ;;^UTILITY(U,$J,358.3,9430,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9430,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT > 64
 ;;^UTILITY(U,$J,358.3,9430,1,3,0)
 ;;=3^99397
 ;;^UTILITY(U,$J,358.3,9431,0)
 ;;=99385^^66^661^1^^^^1
 ;;^UTILITY(U,$J,358.3,9431,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9431,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 18-39
 ;;^UTILITY(U,$J,358.3,9431,1,3,0)
 ;;=3^99385
 ;;^UTILITY(U,$J,358.3,9432,0)
 ;;=99386^^66^661^2^^^^1
 ;;^UTILITY(U,$J,358.3,9432,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9432,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 40-64
 ;;^UTILITY(U,$J,358.3,9432,1,3,0)
 ;;=3^99386
 ;;^UTILITY(U,$J,358.3,9433,0)
 ;;=99387^^66^661^3^^^^1
 ;;^UTILITY(U,$J,358.3,9433,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9433,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT > 64
 ;;^UTILITY(U,$J,358.3,9433,1,3,0)
 ;;=3^99387
 ;;^UTILITY(U,$J,358.3,9434,0)
 ;;=414.01^^67^662^12
 ;;^UTILITY(U,$J,358.3,9434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9434,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,9434,1,5,0)
 ;;=5^Atherosclerosis, native coronary
 ;;^UTILITY(U,$J,358.3,9434,2)
 ;;=CAD, Native Vessel^303281
 ;;^UTILITY(U,$J,358.3,9435,0)
 ;;=413.9^^67^662^2
 ;;^UTILITY(U,$J,358.3,9435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9435,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,9435,1,5,0)
 ;;=5^Angina Pectoris
 ;;^UTILITY(U,$J,358.3,9435,2)
 ;;=Angina Pectoris^87258
 ;;^UTILITY(U,$J,358.3,9436,0)
 ;;=413.0^^67^662^3
 ;;^UTILITY(U,$J,358.3,9436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9436,1,4,0)
 ;;=4^413.0
 ;;^UTILITY(U,$J,358.3,9436,1,5,0)
 ;;=5^Angina at Rest
 ;;^UTILITY(U,$J,358.3,9436,2)
 ;;=Angina at Rest^265313
 ;;^UTILITY(U,$J,358.3,9437,0)
 ;;=411.1^^67^662^5
 ;;^UTILITY(U,$J,358.3,9437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9437,1,4,0)
 ;;=4^411.1
 ;;^UTILITY(U,$J,358.3,9437,1,5,0)
 ;;=5^Angina, Unstable
 ;;^UTILITY(U,$J,358.3,9437,2)
 ;;=Angina, Unstable^7455
 ;;^UTILITY(U,$J,358.3,9438,0)
 ;;=413.1^^67^662^4
 ;;^UTILITY(U,$J,358.3,9438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9438,1,4,0)
 ;;=4^413.1
 ;;^UTILITY(U,$J,358.3,9438,1,5,0)
 ;;=5^Angina, Prinzmetal
 ;;^UTILITY(U,$J,358.3,9438,2)
 ;;=^7448
 ;;^UTILITY(U,$J,358.3,9439,0)
 ;;=V58.61^^67^662^6
 ;;^UTILITY(U,$J,358.3,9439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9439,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,9439,1,5,0)
 ;;=5^Anticoag Rx, chronic
 ;;^UTILITY(U,$J,358.3,9439,2)
 ;;=^303459
